Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

all of these trials; patients remain on treatment in the renal cell cancer trial. Data from the other trials have already been reported.

The NCI has completed patient treatment in a Phase I clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of ispinesib on an alternative dosing schedule in patients with advanced solid tumors that have failed to respond to all standard therapies; data from this trial have already been reported. The NCI is continuing patient enrollment in a Phase I clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of ispinesib on an alternative dosing schedule in patients with relapsed or refractory acute leukemia, chronic myelogenous leukemia in blast crisis, or advanced myelodysplastic syndromes. Data from this trial are expected in 2007.

Background on Mitotic Kinesin Inhibitors

Since their introduction over 40 years ago, anti-mitotic drugs (taxanes and vinca alkaloids) have advanced the treatment of cancer and are commonly used for the treatment of several tumor types. However, these drugs have demonstrated limited treatment benefit against certain cancers. In addition, these drugs target tubulin, a cytoskeletal protein involved not only in mitosis and cell proliferation, but also in other important cellular functions. Inhibition of these other cellular functions produces dose-limiting toxicities such as peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells.

Mitotic kinesins are essential to mitosis, and, unlike tubulin, appear to have no role in other cellular functions. Cytokinetics believes that drugs that inhibit KSP and CENP-E and other mitotic kinesins may represent the next generation of anti-mitotic cancer drugs
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:4/20/2015)... -- Ameritox,s Ingenuity Health, a leading provider of monitoring solutions ... the National Council of Behavioral Health annual conference in ... 25 percent of the samples collected from patients with ... antipsychotic medication. ... Medication nonadherence can ...
(Date:4/20/2015)... 2015 International Isotopes Inc. (OTCQB: INIS, ... with the following update on its business segments. ... Historically, INIS has produced and sold high-activity ... of sealed sources for medical and industrial applications.  ... security examination, and radiography.  Due to technical issues ...
(Date:4/20/2015)... NEW YORK , April 20, 2015 /PRNewswire/ ... insulin pump market will continue to be robust; ... increasing incidence of diabetes, expanding global markets, new ... growth, there are relatively steady market inhibitors, such ... and an increasing competitive environment. The healthcare market ...
Breaking Medicine Technology:Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3
... HASCO Medical, Inc. (OTC Bulletin Board: HASC ... serves patients in Alabama, Florida, and Mississippi, today announced ... additional 8,000+ products available for immediate delivery. ... and affordable for patients throughout the United States to ...
... 25, 2011 Elekta,s MOSAIQ®* oncology electronic ... certification. Complete EMR certification officially validates the Elekta ... demonstrate Stage 1 meaningful use under the HITECH ... the Drummond Group,s Electronic Health Records Office of ...
Cached Medicine Technology:HASCO Medical Expands Online Offering 2Elekta's Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification 2Elekta's Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification 3
(Date:4/21/2015)... The University of Scranton has launched ... to answer the growing demand for professionals trained ... wellness profile for better individual, real-world care. , ... implementation of health services and systems. This is ... operations in the healthcare sector,” says Margarete Zalon, ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 On ... the grand opening of its Center for Graduate ... Hollywood Presbyterian Hospital. The campus recently completed a ... the only thing that has administrators and students ... expanded from the Master of Science in Nursing, ...
(Date:4/21/2015)... Springs, FL (PRWEB) April 21, 2015 ... these are a few of the Earth Day topics ... As state and national leaders debate the affect of ... offers a variety of subject matter touching on the ... The compelling segments will delve into sustainable lifestyles, clean ...
(Date:4/21/2015)... This program provides physical therapists, ... occupational therapist assistants, teachers, and other school based ... children across the autism spectrum succeed in the ... Inc. , Used throughout the United ... yoga curriculum addresses learning and behavior issues across ...
(Date:4/20/2015)... Falls Church, VA (PRWEB) April 21, 2015 ... How Sponsors and CMOs Speed Production and Improve Compliance ... – 3:00 p.m. EDT, http://www.fdanews.com/qualitybydesign , The ... that are forcing them to do more with less. ... forcing sponsors and CMOs to finds ways to speed ...
Breaking Medicine News(10 mins):Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:West Coast University Opens a Center for Graduate Studies 2Health News:West Coast University Opens a Center for Graduate Studies 3Health News:USM Studios’ Programming Focuses on the Environment 2Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3
... RBC Life Sciences (OTC Bulletin Board: RBCL) announced ... Price, to CEO effective January 1, 2009. Company founder, ... chairman of the board of directors.The promotion comes at ... of proprietary nutritional supplements, wound care and pain management ...
... Dental Network of America (DNoA) and Philips Consumer ... America Corporation (Philips), just signed an agreement, effective ... "DNoA Preferred Network" dentists in Illinois, Oklahoma and ... Sonicare(TM) product line."Partnering with Philips on offering the ...
... January 30th noon to 5PM in our new Hyundai Dealer showroom at 271 ... the first 50 to donate blood. , ... Wilmington, MA (PRWEB) January 5, 2009 -- Bill Dube ... blood as the recent ice & snow storms that hit New England have canceled ...
... China, Jan. 5 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain,Drugstore ... "the Company"), the largest retail,drugstore chain in China ... announced that its Board of Directors and the ... termination of a voting rights agreement which,assigned 30% ...
... foods consumed during pregnancy might protect against asthma and ... apple a day while you,re pregnant may indeed keep ... your unborn child. , Recent research suggests ... have lower rates of asthma. , And, mothers who ...
... Today,s fast-paced,demanding culture often makes it challenging to ... health. Karate, which is most commonly,recognized as a means ... to help anyone achieve a fit body; relieve stress; ... her leadership skills. , Karate ...
Cached Medicine News:Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3Health News:Dental Network of America and Philips Sign Agreement to Offer Sonicare Products to Dental Providers 2Health News:Boston Hyundai Dealer Teams up With the Red Cross to Save Lives 2Health News:China Nepstar Chain Drugstore Terminates Voting Rights Agreement for Yunnan Subsidiary 2Health News:China Nepstar Chain Drugstore Terminates Voting Rights Agreement for Yunnan Subsidiary 3Health News:China Nepstar Chain Drugstore Terminates Voting Rights Agreement for Yunnan Subsidiary 4Health News:Prenatal Nutrition, Postnatal Allergy Protection 2Health News:Prenatal Nutrition, Postnatal Allergy Protection 3Health News:Karate For Your Body Announces Release of Volume One in Martial Arts DVD Training Series, 'Focusing On Fundamentals' 2
... The Bledsoe Wee Walker Pediatric ... low profile pediatric boot that ... unsurpassed support. Only two sizes ... cost. These sizes will fit ...
... is a shorter and lighter version ... second degree ankle sprains, toe and ... Bledsoe EZ Set Mid-Calf Boot is ... 20 degrees of dorsi-flexion to 40 ...
... Diabetic Boot features a fully enclosed thick, ... unique auto-molding innersole which embeds into a ... aluminum shelled walking boot. This unique Automold™ ... distribute body weight across the entire bottom ...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: